Pediatrix Medical Group, Inc. (BMV:MD)
323.00
+26.00 (8.75%)
At close: Oct 31, 2025
Pediatrix Medical Group Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 165.39 | -99.07 | -60.41 | 66.34 | 130.96 | Upgrade
|
| Depreciation & Amortization | 21.83 | 32.23 | 36.17 | 35.64 | 32.15 | Upgrade
|
| Loss (Gain) From Sale of Assets | -20.91 | 9.7 | - | - | -7.28 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 178.44 | 148.31 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | 20 | - | - | Upgrade
|
| Stock-Based Compensation | 18.05 | 11.87 | 12.32 | 16.13 | 18.97 | Upgrade
|
| Other Operating Activities | 48.56 | -4.15 | 1.31 | 32.39 | -37.67 | Upgrade
|
| Change in Accounts Receivable | 30.56 | 10.29 | 26.28 | -5.54 | -72.73 | Upgrade
|
| Change in Accounts Payable | 28.33 | 51.14 | -11.92 | 0.42 | 21.33 | Upgrade
|
| Change in Income Taxes | -1.21 | -5.04 | -21.68 | 18.23 | -2.29 | Upgrade
|
| Change in Other Net Operating Assets | -15.85 | 31.84 | -4.31 | 18.73 | 30.32 | Upgrade
|
| Operating Cash Flow | 271.09 | 206.57 | 137.33 | 166.94 | 76.74 | Upgrade
|
| Operating Cash Flow Growth | 31.23% | 50.43% | -17.74% | 117.55% | -62.50% | Upgrade
|
| Capital Expenditures | -18.46 | -22.02 | -33.33 | -29.71 | -32.25 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 24.73 | Upgrade
|
| Cash Acquisitions | -23.2 | -8.17 | -6.67 | -28.17 | -29.93 | Upgrade
|
| Divestitures | 30 | - | - | - | - | Upgrade
|
| Investment in Securities | -3.18 | -12.05 | -8.99 | -0.46 | -18.56 | Upgrade
|
| Other Investing Activities | -3.47 | 6.84 | 0.81 | 1.38 | 2.93 | Upgrade
|
| Investing Cash Flow | -18.3 | -35.41 | -48.18 | -56.95 | -53.07 | Upgrade
|
| Long-Term Debt Issued | - | 235.5 | 470 | 1,480 | - | Upgrade
|
| Long-Term Debt Repaid | -20.75 | -250.89 | -489.12 | -1,885 | -762.66 | Upgrade
|
| Net Debt Issued (Repaid) | -20.75 | -15.39 | -19.12 | -405.17 | -762.66 | Upgrade
|
| Issuance of Common Stock | 3.18 | 3.64 | 4.91 | 5.4 | 6.85 | Upgrade
|
| Repurchase of Common Stock | -86.68 | -1.7 | -0.92 | -88.51 | -4.72 | Upgrade
|
| Other Financing Activities | -3.25 | -1.03 | -10.59 | 0.73 | 0.41 | Upgrade
|
| Financing Cash Flow | -107.49 | -14.49 | -25.72 | -487.55 | -760.12 | Upgrade
|
| Net Cash Flow | 145.3 | 156.68 | 63.43 | -377.57 | -736.45 | Upgrade
|
| Free Cash Flow | 252.63 | 184.55 | 104 | 137.23 | 44.49 | Upgrade
|
| Free Cash Flow Growth | 36.89% | 77.46% | -24.22% | 208.47% | -74.70% | Upgrade
|
| Free Cash Flow Margin | 13.20% | 9.17% | 5.21% | 6.96% | 2.33% | Upgrade
|
| Free Cash Flow Per Share | 2.96 | 2.21 | 1.26 | 1.63 | 0.52 | Upgrade
|
| Cash Interest Paid | 34.38 | 40 | 42.28 | 116.24 | 86.54 | Upgrade
|
| Cash Income Tax Paid | 1.72 | 4.7 | 30.8 | 26.91 | 54.73 | Upgrade
|
| Levered Free Cash Flow | 190.33 | 173.92 | 69.2 | 136.08 | 61.19 | Upgrade
|
| Unlevered Free Cash Flow | 212.81 | 199.39 | 95.5 | 160.89 | 104.14 | Upgrade
|
| Change in Working Capital | 41.83 | 88.24 | -11.63 | 31.83 | -23.37 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.